1 Comerci JT,Licciardi F,Bergh PA,et al.Mature cystic teratoma:a clinicopathologic evaluation of 517 cases and review of the literature.Obstet Gynecol,1994,84:22-28. 2 Emin U,Tayfun G,Cantekin I,et al.Tumor markers in mature cystic teratomas of the ovary.Arch Gynecol Obstet,2009,279:145-147. 3 刘劲松,陈红.检测糖抗原199对卵巢成熟畸胎瘤的诊断价值.中国妇幼保健,2011,20:3155-3156. 4 Cho HY,Kim K,Jeon YT,et al.CA19-9 elevation in ovarian mature cystic teratoma:Discrimination from ovarian cancer CA19-9 level in teratoma.Med Sci Monit,2013,19:230-235. 5 Coskun A,Kiran G,Ozdemir O.CA 19-9 can be a useful tumor marker in ovarian dermoid cysts.Clin Exp Obstet Gynecol,2008,35:137-139. 6 Ugur MG,Ozturk E,Balat O,et al.Do high levels of CA19-9 in women with mature cystic teratomas of the ovary warrant further evaluation? Eur J Gynaecol Oncol,2012,33:207-210. 7 黄贤梅,曾丽梅.CA199在卵巢成熟型畸胎瘤中的应用.中国医药科学,2011,1:122 8 姜靖,邓晓阳,胡晓蕙,等.CA125、CA199和 CEA 联合检测在卵巢癌诊断中的临床意义.中国实验诊断学,2014,7:1145-1148. 9 Kyung MS,Choi JS,Hong SH,et al.Elevated CA 19-9 levels in mature cystic teratoma of the ovary.Int J Biol Markers,2009,24:52-56. 10 Var T,Tonguc EA,Ugur M,et al.Tumor markers panel and tumor size of ovarian dermoid tumors in reproductive age.Bratisl Lek Listy,2012,113:95-98.
